June 2012 Vol. 4 Issue 6

Sponsored Podcasts

Discussing the Latest Research on Citicoline for Brain Function with Researcher Deborah Yurgelun-Todd, PhD

By Natural Medicine Journal
Deborah Yurgelun-Todd, PhD, describes her past and recent research involving natural citicoline. She explains dosage, application, and future potential for this innovative nutrient used to enhance brain function. She also talks about a recent study in the Lancet demonstrating that citicoline had no benefit for ischemic stroke.

Interviews with Experts

Curcumin and Cancer Research

By Natural Medicine Journal
Ajay Goel, PhD, describes his research regarding curcumin and cancer, as well as his recent study involving patients with rheumatoid arthritis. Given recent controversies in curcumin research, Goel also summarizes the scientific validity of this botanical from a much broader perspective.

Abstracts & Commentary

Cannabinoid-Opioid Interaction in Chronic Pain

By Kevin Spelman, PhD, MCPP
Donald Abrams, MD, a University of California-San Francisco researcher and clinician who brings a rational approach to Cannabis use, is to be credited for forging another path forward in the use of medical marijuana. Although a placebo-controlled study previously showed that oral THC in patients using opioids augments analgesia, this is the first human study to show that inhaled cannabis safely potentiates the analgesia of opioids.

Fish Oil Supplement Improves Quality of Life in Patients with Lung Cancer

By Tina Kaczor, ND, FABNO
In a randomized, double-blind, placebo-controlled trial, 33 patients with with stage IIIa or IIIb non-small cell lung cancer were given either a liquid supplement containing omega-3 fatty acids or an isocaloric equivalent for 5 weeks.

Statin Use Increases the Risk of Diabetes Mellitus in Postmenopausal Women

By Michael T. Murray, ND
This study investigated whether the incidence of new-onset diabetes mellitus (DM) is associated with statin use among postmenopausal women participating in the Women's Health Initiative (WHI).

Ginger May Reduce Colorectal Cancer Risk

By Jacob Schor, ND, FABNO
Participants in this study underwent 2 flexible sigmoidoscopies, one before ginger treatment and the second 28 days after starting to take the ginger. The second procedure was performed as close as possible to 24 hours after the participant took the final dose of ginger. There were no significant differences in mean percent change between baseline and day 28 for any of the eicosanoids, when normalized to protein, however this study brings us a step closer to understanding whether ginger could be used to prevent colorectal cancer.

Survival Rates in Gastric Cancer Patients Using Lentinan

By Michael Traub, ND, DHANP, FABNO
Study suggests that chemo-immunotherapy with lentinan provides a survival advantage in patients with inoperable gastric cancer. This is the most recent investigation of lentinan used for this purpose in a number of studies going back to at least 1983, where it was reported that it improved survival, immune response, and hematological measures in advanced or recurrent gastric, colorectal, and breast carcinomas.

Use of Serum Magnesium Measurements to Exclude Magnesium Deficiency is Cause for Concern

By Carolyn Dean, MD, ND
Magnesium deficiency was found to be associated with increased prevalence and risk in 11 major health conditions. In 68 of the 183 peer-reviewed studies, magnesium deficiency was found to predict adverse events, and a decreased risk of pathology was noted when supplementation or treatment was instituted.

Healthcare Perspectives

Registration is Open for 27th Annual AANP Conference

By Jacob Schor, ND, FABNO
The American Association of Naturopathic Physicians will hold its 27th annual conference at the Hyatt Regency Hotel in Bellevue, Wash., August 15-18, 2012.

Peer-Reviewed Articles

Assessing Egg Quantity with Anti-Mullerian Hormone

By Setareh Tais, ND
Diminished ovarian reserve, a natural process by which the follicular pool diminishes with time, is often clinically asymptomatic but presents a challenge to those wanting to become pregnant. Although pelvic ultrasonography and day 3 serum hormone testing have long been common methods of assessing ovarian reserve, there is promising research to suggest the utility of anti-Mullerian hormone testing to identify patients with diminished ovarian reserve.

Special Thanks to Our Key Sponsors